These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34240839)

  • 1. Can selective serotonin reuptake inhibitors/serotonin and norepinephrine reuptake inhibitor antidepressants decrease the "cytokine storm" in the course of COVID-19 pneumonia?
    Fei L; Santarelli G; D'Anna G; Moretti S; Mirossi G; Patti A; Sanfilippo G; Almerigogna F; Berni A; Caldini E; Lagi F; Para O; Vaudo M; Vultaggio A
    Panminerva Med; 2023 Sep; 65(3):321-326. PubMed ID: 34240839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of antidepressants on the severity of COVID-19 in hospitalized patients: A systematic review and meta-analysis.
    Nakhaee H; Zangiabadian M; Bayati R; Rahmanian M; Ghaffari Jolfayi A; Rakhshanderou S
    PLoS One; 2022; 17(10):e0267423. PubMed ID: 36201406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid response to selective serotonin reuptake inhibitors in post-COVID depression.
    Mazza MG; Zanardi R; Palladini M; Rovere-Querini P; Benedetti F
    Eur Neuropsychopharmacol; 2022 Jan; 54():1-6. PubMed ID: 34634679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of Flibanserin in Women Treated With Antidepressants: A Randomized, Placebo-Controlled Study.
    Clayton AH; Croft HA; Yuan J; Brown L; Kissling R
    J Sex Med; 2018 Jan; 15(1):43-51. PubMed ID: 29289374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Abrupt Discontinuation of Antidepressants in Critically Ill Hospitalized Adults.
    Bainum TB; Fike DS; Mechelay D; Haase KK
    Pharmacotherapy; 2017 Oct; 37(10):1231-1240. PubMed ID: 28730691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.
    Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M
    CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
    Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
    Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New-Generation, Non-SSRI Antidepressants: Therapeutic Drug Monitoring and Pharmacological Interactions. Part 1: SNRIs, SMSs, SARIs.
    Mandrioli R; Protti M; Mercolini L
    Curr Med Chem; 2018; 25(7):772-792. PubMed ID: 28707591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.
    Khandker RK; Kruzikas DT; McLaughlin TP
    J Manag Care Pharm; 2008 Jun; 14(5):426-41. PubMed ID: 18597572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 Outcomes: Does the Use of Psychotropic Drugs Make a Difference? Accumulating Evidence of a Beneficial Effect of Antidepressants-A Scoping Review.
    Bonnet U; Juckel G
    J Clin Psychopharmacol; 2022 May-Jun 01; 42(3):284-292. PubMed ID: 35420565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States.
    Palmsten K; Hernández-Díaz S; Huybrechts KF; Williams PL; Michels KB; Achtyes ED; Mogun H; Setoguchi S
    BMJ; 2013 Aug; 347():f4877. PubMed ID: 23965506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal markers of therapeutic responses in major depressive disorder: Effects of antidepressants on retinal function.
    Moulard M; Cosker E; Angioi-Duprez K; Laprévote V; Schwan R; Schwitzer T
    J Psychiatr Res; 2022 Oct; 154():71-79. PubMed ID: 35932524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective Serotonin Reuptake Inhibitors and Serotonin and Noradrenaline Reuptake Inhibitors Improve Cognitive Function in Partial Responders Depressed Patients: Results from a Prospective Observational Cohort Study.
    Castellano S; Ventimiglia A; Salomone S; Ventimiglia A; De Vivo S; Signorelli MS; Bellelli E; Santagati M; Cantarella RA; Fazio E; Aguglia E; Drago F; Di Nuovo S; Caraci F
    CNS Neurol Disord Drug Targets; 2016; 15(10):1290-1298. PubMed ID: 27712575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Depression Onset and Treatment With Blood Pressure Control After Intracerebral Hemorrhage.
    Keins S; Abramson JR; Mallick A; Castello JP; Rodriguez-Torres A; Popescu D; Hoffman D; Kourkoulis C; Gurol ME; Greenberg SM; Anderson CD; Viswanathan A; Rosand J; Biffi A
    Stroke; 2023 Jan; 54(1):105-112. PubMed ID: 36444719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT.
    Kessler D; Burns A; Tallon D; Lewis G; MacNeill S; Round J; Hollingworth W; Chew-Graham C; Anderson I; Campbell J; Dickens C; Macleod U; Gilbody S; Davies S; Peters TJ; Wiles N
    Health Technol Assess; 2018 Nov; 22(63):1-136. PubMed ID: 30468145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective serotonin reuptake inhibitor (SSRI) antidepressants reduce COVID-19 infection: prospects for use.
    Foletto VS; da Rosa TF; Serafin MB; Hörner R
    Eur J Clin Pharmacol; 2022 Oct; 78(10):1601-1611. PubMed ID: 35943535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
    Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
    Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does adding noradrenaline reuptake inhibition to selective serotonin reuptake inhibition improve efficacy in patients with depression? A systematic review of meta-analyses and large randomised pragmatic trials.
    Bradley AJ; Lenox-Smith AJ
    J Psychopharmacol; 2013 Aug; 27(8):740-58. PubMed ID: 23832963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.